International Clinical Trial: To assess the usability and clinical utility of a Medical Artificial Intelligence System with different consumer groups in the Pompe Disease community

Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (ACTRN12626000943347) titled 'To assess the usability and clinical utility of a Medical Artificial Intelligence System with different consumer groups in the Pompe Disease community' on July 30.

Study Type: Interventional

Study Design: Purpose: Diagnosis Allocation: Non-randomised trial

Primary Sponsor: David Cavanagh, Integrated Energy Pty Ltd

Condition: Pompe Disease Pompe Disease Human Genetics and Inherited Disorders - Other human genetics and inherited disorders Musculoskeletal - Other muscular and skeletal disorders

Intervention: Description of intervention or exposure: The intervention under investigation is the Mia AI clinical...